Home MAPK MNK

MNK

Isoform-selective Products

MNK Products

  • All (4)
  • MNK Inhibitors (4)
  • New MNK Products
Catalog No. Product Name Information Product Use Citations Product Validations
S8275 Tomivosertib (eFT-508) Tomivosertib (eFT-508) is a potent and selective MNK1/2 inhibitor with IC50s of 2.4 nM and 1 nM, respectively. It potentially results in decreased tumor cell proliferation and tumor growth. Tomivosertib (eFT-508) inhibits eIF4E phosphorylation and dramatically downregulates PD-L1 protein abundance.
J Clin Invest, 2024, 134(16)e168393
Sci Adv, 2024, 10(37):eadi7673
PLoS Biol, 2023, 21(8):e3002227
S7421 CGP 57380 CGP 57380 is a potent MNK1 inhibitor with IC50 of 2.2 μM, exhibiting no inhibitory activity on p38, JNK1, ERK1 and -2, PKC, or c-Src-like kinases. CGP 57380 upregulates β-catenin and potentiates radiation-induced apoptosis.
Cell Commun Signal, 2023, 21(1):107
Fundam Clin Pharmacol, 2022, 10.1111/fcp.12759
J Cancer, 2020, 11(4):990-996
S6888 SEL201 SEL-201 (SLV-2436, SEL201-88) is a highly potent and ATP-competitive inhibitor of MNK1 and MNK2 with IC50 of 10.8  nM and 5.4 nM, respectively.
Eur J Pharm Sci, 2022, 177:106278
S6658 ETC-206 (AUM 001) ETC-206 (AUM 001, ETC-1907206) is an orally available highly selective small-molecule MNK 1/2 inhibitor with IC50s of 64 nM and 86 nM, respectively.
S8275 Tomivosertib (eFT-508) Tomivosertib (eFT-508) is a potent and selective MNK1/2 inhibitor with IC50s of 2.4 nM and 1 nM, respectively. It potentially results in decreased tumor cell proliferation and tumor growth. Tomivosertib (eFT-508) inhibits eIF4E phosphorylation and dramatically downregulates PD-L1 protein abundance.
J Clin Invest, 2024, 134(16)e168393
Sci Adv, 2024, 10(37):eadi7673
PLoS Biol, 2023, 21(8):e3002227
S7421 CGP 57380 CGP 57380 is a potent MNK1 inhibitor with IC50 of 2.2 μM, exhibiting no inhibitory activity on p38, JNK1, ERK1 and -2, PKC, or c-Src-like kinases. CGP 57380 upregulates β-catenin and potentiates radiation-induced apoptosis.
Cell Commun Signal, 2023, 21(1):107
Fundam Clin Pharmacol, 2022, 10.1111/fcp.12759
J Cancer, 2020, 11(4):990-996
S6888 SEL201 SEL-201 (SLV-2436, SEL201-88) is a highly potent and ATP-competitive inhibitor of MNK1 and MNK2 with IC50 of 10.8  nM and 5.4 nM, respectively.
Eur J Pharm Sci, 2022, 177:106278
S6658 ETC-206 (AUM 001) ETC-206 (AUM 001, ETC-1907206) is an orally available highly selective small-molecule MNK 1/2 inhibitor with IC50s of 64 nM and 86 nM, respectively.

Choose Selective MNK Inhibitors

Tags: MNK activty | MNK inhibitor | MNK inhibitor review